studi standarisasi radioterapi cobalt-60 terhadap kuantitas sel darah pada penderita kanker serviks (cancer cervics) di rsup sanglah denpasar
Clicks: 73
ID: 221795
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
21.6
/100
73 views
8 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #8 of 9 articles by views in drugs and aging
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
After doing research with Title Study of Cobalt-60 radiotherapy Standards Against Quantity Blood Cells In Patients with Cervical Cancer (Cancer Cervics) at Sanglah Hospital in Denpasar. This study uses secondary data such as a complete blood from each patient with cervical cancer in 2015 that radiotherapy with fractionation method. The amount of patient data used in this study is 5 pieces. The quantity of blood cells that are analyzed include RBC, HGB, WBC and WBC Components (LY, EO, EO, BA, NE, MO). Fractionation dose is 800-5800cGy. The results of data analysis showed that each blood cell components are still within the range of 2-50%, so a method of radiotherapy is still fit for use.
| Reference Key |
ulan2017buletinstudi
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Retianingsih Oeta Ulan;Gusti Ngurah Sutapa;Wayan Balik Sudarsana |
| Journal | drugs and aging |
| Year | 2017 |
| DOI |
10.24843/BF.2017.v18.i02.p04
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.